MedPath

A Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares

Phase 2
Completed
Conditions
Verrucae Vulgares
Registration Number
NCT00228332
Lead Sponsor
University Hospital, Ghent
Brief Summary

A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares

Detailed Description

A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients with verrucae vulgares
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Disappearence of the verrucae vulgares after 3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Ghent

🇧🇪

Ghent, Belgium

© Copyright 2025. All Rights Reserved by MedPath